BioSmart Research
About this raise
BioSmart Research, with a valuation cap of $20 million, is raising funds on Wefunder. The company is making over-the-counter CBD nutraceuticals for pain management, anxiety, skincare, and neurological disorders. BioSmart Research uses chromatography technologies to produce specific cannabinoid formulas to treat specific conditions. B Renee Searle founded BioSmart Research in March 2019. The current crowdfunding round has a minimum target of $50,000 and a maximum target of $1,070,000, and the funds will be used for marketing expenses, paying off an existing equipment note, opening a retail dispensary, and inventories. BioSmart Research sells through its own dispensaries, healthcare providers, pharmacies, and affiliates and has generated $1.7 million in lifetime sales.
Investment Overview
Invested : $53,400
Deal Terms
Total Commitments
- Platform
- Wefunder
- Start Date
- 07/14/2021
- Close Date
- 12/22/2021
$50,000
$1,070,000
$100
Convertible Note
Pre-Seed
RegCF
$15,000,000
$20,000,000
20%
Company & Team
Company
- Year Founded
- 2019
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- Low
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 12/22/2021 | Wefunder | $20,000,000 | $53,400 | Convertible Note | Funded | RegCF |